Kenneth C. Carter, President and CEO at AVALON PHARMACEUTICALS INC (AVRX), bought 2,000 shares at $3.28 ($7K) on 2006-08-22, disclosed to the SEC on 2006-08-24.
Open-market purchase of $7k AVRX by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.26 | 900 | $3K | 44.9% |
| 2 | $3.27 | 100 | $327 | 5.0% |
| 3 | $3.28 | 1,000 | $3K | 50.1% |
| Total | $3.27 avg | 2,000 | $7K | 100% |
| Filing → |
| AVRX | SELL | 2008-01-23 | $5K | — | Filing → |
| AVRX | BUY | 2006-08-31 | $9K | — | Filing → |